Literature DB >> 21308355

[Hotline for malignant hyperthermia. New telephone number for the German nationwide 24 h service center: 08221/9600].

W Klingler1, F Lehmann-Horn, U Schulte-Sasse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21308355     DOI： 10.1007/s00101-011-1851-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  22 in total

Review 1.  Malignant hyperthermia: advances in clinical management and diagnosis.

Authors:  P M Hopkins
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.

Authors:  A Urwyler; T Deufel; T McCarthy; S West
Journal:  Br J Anaesth       Date:  2001-02       Impact factor: 9.166

3.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

Review 4.  [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].

Authors:  Frank Schuster; Clemens R Müller-Reible
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2009-11-16       Impact factor: 0.698

Review 5.  Complications of anaesthesia in neuromuscular disorders.

Authors:  Werner Klingler; Frank Lehmann-Horn; Karin Jurkat-Rott
Journal:  Neuromuscul Disord       Date:  2005-01-28       Impact factor: 4.296

Review 6.  Malignant hyperthermia and excitation-contraction coupling.

Authors:  W Melzer; B Dietze
Journal:  Acta Physiol Scand       Date:  2001-03

7.  Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.

Authors:  N Monnier; N B Romero; J Lerale; P Landrieu; Y Nivoche; M Fardeau; J Lunardi
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

8.  Molecular genetic testing for malignant hyperthermia susceptibility.

Authors:  Thierry Girard; Susan Treves; Evgueni Voronkov; Martin Siegemund; Albert Urwyler
Journal:  Anesthesiology       Date:  2004-05       Impact factor: 7.892

9.  A clinical grading scale to predict malignant hyperthermia susceptibility.

Authors:  M G Larach; A R Localio; G C Allen; M A Denborough; F R Ellis; G A Gronert; R F Kaplan; S M Muldoon; T E Nelson; H Ording
Journal:  Anesthesiology       Date:  1994-04       Impact factor: 7.892

Review 10.  Malignant hyperthermia.

Authors:  Henry Rosenberg; Mark Davis; Danielle James; Neil Pollock; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2007-04-24       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.